{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:04:08Z","timestamp":1778598248940,"version":"3.51.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.biopsych.2012.06.023","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T02:38:46Z","timestamp":1343097526000},"page":"24-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["A Critical Review of Magnetic Resonance Spectroscopy Studies of Obsessive-Compulsive Disorder"],"prefix":"10.1016","volume":"73","author":[{"given":"Brian P.","family":"Brennan","sequence":"first","affiliation":[]},{"given":"Scott L.","family":"Rauch","sequence":"additional","affiliation":[]},{"given":"J. Eric","family":"Jensen","sequence":"additional","affiliation":[]},{"suffix":"Jr.","given":"Harrison G.","family":"Pope","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.06.023_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1056\/NEJMcp031002","article-title":"Clinical practice","volume":"350","author":"Jenike","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2012.06.023_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2004.00302.x","article-title":"Long-term outcome of pediatric obsessive-compulsive disorder: A meta-analysis and qualitative review of the literature","volume":"110","author":"Stewart","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2012.06.023_bib4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1176\/appi.ajp.158.11.1899","article-title":"Adults with early-onset obsessive-compulsive disorder","volume":"158","author":"Rosario-Campos","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0193-953X(05)70181-7","article-title":"Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder","volume":"23","author":"Saxena","year":"2000","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.biopsych.2012.06.023_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archpsyc.1987.01800150017003","article-title":"Local cerebral glucose metabolic rates in obsessive-compulsive disorder","volume":"44","author":"Baxter","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0893-133X(89)90003-1","article-title":"Cerebral glucose metabolic rates in obsessive compulsive disorder","volume":"2","author":"Nordahl","year":"1989","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.06.023_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.1989.01810060038007","article-title":"Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder","volume":"46","author":"Swedo","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3956(00)00022-4","article-title":"fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder","volume":"34","author":"Adler","year":"2000","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archpsyc.1996.01830070041008","article-title":"Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder","volume":"53","author":"Breiter","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1994.03950010062008","article-title":"Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography","volume":"51","author":"Rauch","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.1992.01820090009002","article-title":"Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder","volume":"49","author":"Baxter","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archpsyc.1990.01810210048007","article-title":"Local cerebral glucose metabolic rates in obsessive-compulsive disorder","volume":"47","author":"Benkelfat","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/archpsyc.59.3.250","article-title":"Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression","volume":"59","author":"Saxena","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archpsyc.1992.01820090018003","article-title":"Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder","volume":"49","author":"Swedo","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pscychresns.2004.06.007","article-title":"Amygdala activity in obsessive-compulsive disorder with contamination fear: A study with oxygen-15 water positron emission tomography","volume":"132","author":"van den Heuvel","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0925-4927(02)00104-X","article-title":"Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder","volume":"122","author":"Kwon","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2012.06.023_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/nbdi.1997.0153","article-title":"The nagging question of the function of N-acetylaspartylglutamate","volume":"4","author":"Coyle","year":"1997","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2012.06.023_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","article-title":"Proton NMR chemical shifts and coupling constants for brain metabolites","volume":"13","author":"Govindaraju","year":"2000","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2012.06.023_bib21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","article-title":"Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders","volume":"68","author":"Y\u00fcksel","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(97)00016-4","article-title":"1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: Evidence for neuronal loss in the cingulate gyrus and the right striatum","volume":"74","author":"Ebert","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib23","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1176\/ajp.155.11.1584","article-title":"A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects","volume":"155","author":"Bartha","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pscychresns.2007.04.002","article-title":"Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: A pilot investigation comparing treatment responders and non\u2013responders","volume":"156","author":"Mohamed","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.64.8.946","article-title":"Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder","volume":"64","author":"Y\u00fccel","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pscychresns.2006.02.003","article-title":"Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients","volume":"154","author":"Sumitani","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0447.2011.01726.x","article-title":"The involvement of distinct neural systems in patients with obsessive-compulsive disorder with autogenous and reactive obsessions","volume":"124","author":"Besiroglu","year":"2011","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2012.06.023_bib28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1176\/ajp.2006.163.7.1202","article-title":"A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder","volume":"163","author":"Jang","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0006-3223(99)00286-3","article-title":"Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder","volume":"47","author":"Fitzgerald","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1440-1819.2009.01993.x","article-title":"Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder","volume":"63","author":"Atmaca","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2012.06.023_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/00048670802050546","article-title":"Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder","volume":"42","author":"Y\u00fccel","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1440-1819.2010.02128.x","article-title":"Increased N-Acetylaspartate\/creatine ratio in the medial prefrontal cortex among unmedicated obsessive-compulsive disorder patients","volume":"64","author":"Fan","year":"2010","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2012.06.023_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pnpbp.2011.09.007","article-title":"MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder","volume":"36","author":"O'Neill","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2012.06.023_bib34","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1089\/104454603322126322","article-title":"Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder","volume":"13","author":"Russell","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.06.023_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pscychresns.2005.12.006","article-title":"A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety","volume":"146","author":"Whiteside","year":"2006","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pscychresns.2011.04.004","article-title":"The effect of behavior therapy on caudate N-acetyl-l-aspartic acid in adults with obsessive-compulsive disorder","volume":"201","author":"Whiteside","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00004583-199806000-00017","article-title":"Case study: Caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder","volume":"37","author":"Moore","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00004583-200108000-00011","article-title":"Case study: Caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD","volume":"40","author":"Bolton","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib39","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.chi.0000087562.01900.de","article-title":"Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy","volume":"42","author":"Benazon","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib40","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/01.chi.0000132812.44664.2d","article-title":"Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls","volume":"43","author":"Rosenberg","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pscychresns.2009.02.005","article-title":"Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder","volume":"172","author":"Arnold","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib42","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","article-title":"Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine","volume":"39","author":"Rosenberg","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib43","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00702-008-0045-4","article-title":"A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: Relationship between metabolite concentrations and symptom severity","volume":"115","author":"Starck","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.biopsych.2012.06.023_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pscychresns.2011.01.017","article-title":"Proton magnetic resonance spectroscopy in pediatric obsessive-compulsive disorder: Longitudinal study before and after treatment","volume":"201","author":"L\u00e1zaro","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib45","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/088307380101600902","article-title":"Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging","volume":"16","author":"Rosenberg","year":"2001","journal-title":"J Child Neurol"},{"key":"10.1016\/j.biopsych.2012.06.023_bib46","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0006-3223(03)00474-8","article-title":"Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: A magnetic resonance spectroscopy study","volume":"54","author":"Smith","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0447.2006.00858.x","article-title":"Parietal white matter abnormalities in obsessive-compulsive disorder: A magnetic resonance spectroscopy study at 3-Tesla","volume":"114","author":"Kitamura","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2012.06.023_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/08830738060210020201","article-title":"Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls","volume":"21","author":"Mirza","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.biopsych.2012.06.023_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0301-0082(95)00014-M","article-title":"N-acetylaspartate in neuropsychiatric disorders","volume":"46","author":"Tsai","year":"1995","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2012.06.023_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1192\/bjp.bp.108.055046","article-title":"Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder","volume":"195","author":"Radua","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biopsych.2008.06.019","article-title":"Meta-analysis of brain volume changes in obsessive-compulsive disorder","volume":"65","author":"Rotge","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib52","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archgenpsychiatry.2010.70","article-title":"Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders","volume":"67","author":"Radua","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archpsyc.1995.03950170067009","article-title":"Reduced caudate nucleus volume in obsessive-compulsive disorder","volume":"52","author":"Robinson","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib54","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archpsyc.1997.01830210068007","article-title":"Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder","volume":"54","author":"Rosenberg","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mrm.21234","article-title":"In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla","volume":"57","author":"Edden","year":"2007","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.biopsych.2012.06.023_bib56","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2012.06.023_bib57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000017327","article-title":"Functional energy metabolism: in vivo 13C-NMR spectroscopy evidence for coupling of cerebral glucose consumption and glutamatergic neuronalactivity","volume":"20","author":"Sibson","year":"1998","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.biopsych.2012.06.023_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pscychresns.2010.10.008","article-title":"Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: The importance of considering subclinical symptoms of anxiety and depression","volume":"192","author":"Bedard","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib59","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature06104","article-title":"Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice","volume":"448","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2012.06.023_bib60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1875397300802010062","article-title":"Glutamatergic synaptic dysfunction and obsessive-compulsive disorder","volume":"2","author":"Ting","year":"2008","journal-title":"Curr Chem Genomics"},{"key":"10.1016\/j.biopsych.2012.06.023_bib61","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/0024-3205(96)00182-8","article-title":"In vivo 1H MRS choline: Correlation with in vitro chemistry\/histology","volume":"58","author":"Miller","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.biopsych.2012.06.023_bib62","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/nbm.1621","article-title":"Combined (1)H and (31)P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis","volume":"24","author":"Hattingen","year":"2011","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2012.06.023_bib63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.410360110","article-title":"Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging","volume":"36","author":"Meyerhoff","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2012.06.023_bib64","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2012.06.023_bib65","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.410310302","article-title":"Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques","volume":"31","author":"Arnold","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2012.06.023_bib66","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/da.20246","article-title":"A diffusion tensor imaging study of white matter in obsessive-compulsive disorder","volume":"24","author":"Cannistraro","year":"2007","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2012.06.023_bib67","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/archpsyc.62.7.782","article-title":"White matter abnormalities in obsessive-compulsive disorder: A diffusion tensor imaging study","volume":"62","author":"Szeszko","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0447.2007.01046.x","article-title":"White matter abnormalities in drug-naive patients with obsessive-compulsive disorder: A diffusion tensor study before and after citalopram treatment","volume":"116","author":"Yoo","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2012.06.023_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archpsyc.64.2.209","article-title":"A genetic family-based association study of OLIG2 in obsessive-compulsive disorder","volume":"64","author":"Stewart","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0925-4927(99)00040-2","article-title":"Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder","volume":"92","author":"Ohara","year":"1999","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib71","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/jmri.21144","article-title":"In vivo proton magnetic resonance spectroscopy in patients with mood disorders: A technically oriented review","volume":"26","author":"Capizzano","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.biopsych.2012.06.023_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pscychresns.2005.12.004","article-title":"Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: A meta-analysis","volume":"147","author":"Yildiz-Yesiloglu","year":"2006","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib73","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/appi.ajp.161.6.1119","article-title":"Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: A proton magnetic resonance spectroscopic imaging study","volume":"161","author":"Mathew","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib74","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1038\/sj.npp.1301387","article-title":"Increased anterior cingulate\/medial prefrontal cortical glutamate and creatine in bipolar depression","volume":"32","author":"Frye","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.06.023_bib75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pscychresns.2008.06.002","article-title":"Creatine abnormalities in schizophrenia and bipolar disorder","volume":"172","author":"\u00d6ng\u00fcr","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib76","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mrm.1119","article-title":"Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging","volume":"45","author":"Schuff","year":"2001","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.biopsych.2012.06.023_bib77","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1176\/appi.ajp.162.2.228","article-title":"A multidimensional model of obsessive-compulsive disorder","volume":"162","author":"Mataix-Cols","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib78","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jpsychires.2011.10.016","article-title":"White matter structure and symptom dimensions in obsessive-compulsive disorder","volume":"46","author":"Koch","year":"2012","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib79","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jad.2007.12.223","article-title":"Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study","volume":"109","author":"Gilbert","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2012.06.023_bib80","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archpsyc.61.6.564","article-title":"Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder","volume":"61","author":"Mataix-Cols","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib81","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/CHI.0b013e3181b2163c","article-title":"Neural correlates of symptom dimensions in pediatric obsessive-compulsive disorder: A functional magnetic resonance imaging study","volume":"48","author":"Gilbert","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib82","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ajmg.b.30914","article-title":"A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families","volume":"150B","author":"Shugart","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biopsych.2012.06.023_bib83","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ajmg.b.30533","article-title":"Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder","volume":"144B","author":"Stewart","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biopsych.2012.06.023_bib84","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archpsyc.63.7.769","article-title":"Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder","volume":"63","author":"Arnold","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib85","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/archpsyc.63.7.778","article-title":"Association testing of the positional and functional candidate gene SLC1A1\/EAAC1 in early-onset obsessive-compulsive disorder","volume":"63","author":"Dickel","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib86","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajmg.b.31184","article-title":"Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder","volume":"156B","author":"Samuels","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biopsych.2012.06.023_bib87","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/archgenpsychiatry.2009.6","article-title":"A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder","volume":"66","author":"Wendland","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib88","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/nbm.1390","article-title":"Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla","volume":"22","author":"Jensen","year":"2009","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2012.06.023_bib89","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/npp.2009.191","article-title":"Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole","volume":"35","author":"Brennan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2012.06.023_bib90","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1471-4159.2002.01161.x","article-title":"Glial uptake of neurotransmitter glutamate from the extracellular fluid studied in vivo by microdialysis and (13)C NMR","volume":"83","author":"Kanamori","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2012.06.023_bib91","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/nbm.1646","article-title":"Noninvasive quantification of ascorbate and glutathione concentration in the elderly human brain","volume":"24","author":"Emir","year":"2011","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2012.06.023_bib92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1099-1492(199704)10:2<73::AID-NBM448>3.0.CO;2-4","article-title":"Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS","volume":"10","author":"Pouwels","year":"1997","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2012.06.023_bib93","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jpsychires.2011.09.012","article-title":"Genetic variants in nuclear-encoded mitochondrial proteins are associated with oxidative stress in obsessive compulsive disorders","volume":"46","author":"Orhan","year":"2012","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2012.06.023_bib94","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.physbeh.2011.03.008","article-title":"Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse","volume":"103","author":"Guldenpfennig","year":"2011","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2012.06.023_bib95","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pnpbp.2007.10.002","article-title":"Oxidative imbalance in obsessive compulsive disorder patients: A total evaluation of oxidant-antioxidant status","volume":"32","author":"Selek","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.06.023_bib96","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1471-4159.2006.03978.x","article-title":"The neuronal excitatory amino acid transporter EAAC1\/EAAT3: Does it represent a major actor at the brain excitatory synapse?","volume":"98","author":"Nieoullon","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2012.06.023_bib97","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn1609","article-title":"Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse","volume":"9","author":"Aoyama","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2012.06.023_bib98","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/nbm.994","article-title":"Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging","volume":"18","author":"Jensen","year":"2005","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2012.06.023_bib99","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1755-5949.2009.00130.x","article-title":"Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder: A family-based study","volume":"17","author":"Sampaio","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.biopsych.2012.06.023_bib100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00213-004-1847-1","article-title":"Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: A preliminary study","volume":"174","author":"Arnold","year":"2004","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312005586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312005586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:59:56Z","timestamp":1762099196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312005586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0006322312005586"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.06.023","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Critical Review of Magnetic Resonance Spectroscopy Studies of Obsessive-Compulsive Disorder","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}